|
|
Vaccine Detail
|
ChAd-triCoV/Mac |
| Vaccine Information |
- Vaccine Name: ChAd-triCoV/Mac
- Target Pathogen: SARS-CoV-2
- Target Disease: COVID-19
- Manufacturer: McMaster University
- Vaccine Ontology ID: VO_0005342
- Type: Recombinant vector vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Antigen: S1 region of SARS-CoV-2 spike protein (aa 47-716) and full-length SARS-CoV-2 nucleoprotein (N) fused to a highly conserved portion of the SARS-CoV-2 polymerase (RdRp or POL)
- Immunization Route: intranasal immunization
|
| Host Response |
|
|
| References |
|
|
|
